Autres langues Becton, Dickinson and Company London S.E.

Actions

0R19

US0758871091

Equipement, fournitures et distribution médicale

Marché Fermé - London S.E. 17:14:58 22/09/2026			Après clôture 18:21:57
181,72 ^USD	+0,54%		181,97	+0,14%

21/09	Becton, Dickinson nomme Arthur Hu au poste de Chief Information and Digital Officer	MT
21/09	Becton, Dickinson and Company annonce la nomination d'Arthur Hu au poste de vice-président exécutif et directeur de l'information et du numérique, à compter du 30 septembre 2026	CI

Autres langues

21/09	Becton, Dickinson Names Arthur Hu Chief Information, Digital Officer
21/09	Arthur Hu to Join BD as Chief Information and Digital Officer
21/09	Becton, Dickinson and Company Announces Appointment of Arthur Hu as Executive Vice President and Chief Information and Digital Officer, Effective September 30, 2026
18/09	Jana urges Cooper to replace CEO, explore asset sales after performance setbacks
14/09	Becton, Dickinson And Company Deploys BD Vmax 160 Pharmacy Automation Robot At Fairview Health Services
14/09	BD Advances Intelligent Robotics to Transform the Future of Pharmacy Care at Fairview
10/09	Becton Dickinson and : BD Celebrates 30 Years of Innovation and Shared Prosperity in Enniscorthy
01/09	Medtronic Raises Full-Year Outlook Following Fiscal First-Quarter Beat
27/08	Becton Dickinson Reaches 50% Enrollment in Breast Surgery Trial
27/08	BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation
26/08	BD to Present at Wells Fargo 21st Annual Healthcare Conference
17/08	Becton, Dickinson and Company Announces Management Changes
17/08	Becton Dickinson Names Gary Sorsher as Chief Quality Officer
17/08	BD Appoints Gary Sorsher as Chief Quality Officer; Jeff Silvestri to Retire
17/08	Jeffrey Silvestri to Retire as Senior Vice President, Global Head of Quality of Becton, Dickinson and Company in October 2026
13/08	Becton, Dickinson's Consistent Mid-Single-Digit Organic Growth is 12-18 Months Away, RBC Says
12/08	Becton Dickinson & Co Insider Sold Shares Worth $440,888, According to a Recent SEC Filing
12/08	Becton, Dickinson Completes Enrollment in Trial for Phasix Mesh
12/08	BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial
12/08	Becton, Dickinson And Company Completes Enrollment In The PREVENT Clinical Trial Evaluating Phasix Mesh For Incisional Hernia Prevention
07/08	Becton, Dickinson's Fiscal Q3 Results Show Progress Amid Major Headwinds, RBC Says
06/08	Tranche Update on Becton, Dickinson and Company's Equity Buyback Plan announced on January 28, 2025.
06/08	Tranche Update on Becton, Dickinson and Company's Equity Buyback Plan announced on January 27, 2026.
06/08	Becton Dickinson Lifts Full-Year Profit Outlook as Third-Quarter Results Top Views
06/08	Becton, Dickinson and Company Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2026